Study of BHV-1400 in IgA Nephropathy

Last updated: March 6, 2026
Sponsor: Biohaven Therapeutics Ltd.
Overall Status: Active - Recruiting

Phase

1

Condition

Glomerulonephritis

Nephritis

Kidney Disease

Treatment

BHV-1400

Clinical Study ID

NCT07054684
BHV1400-102
  • Ages 18-65
  • All Genders

Study Summary

The purpose of this study is to determine if BHV-1400 is a safe and tolerable treatment in participants with IgA Nephropathy (IgAN).

Eligibility Criteria

Inclusion

Key Inclusion Criteria:

  1. Participants must have biopsy-confirmed IgA Nephropathy

Exclusion

Key Exclusion Criteria:

  1. Any secondary IgAN

  2. Any cause of chronic kidney disease not diagnosed as IgAN or due to non-IgAN cause

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: BHV-1400
Phase: 1
Study Start date:
July 30, 2025
Estimated Completion Date:
July 31, 2027

Connect with a study center

  • Site-007

    Leicester, LE5 4PW
    United Kingdom

    Active - Recruiting

  • Site-007

    Leicester 2644668, LE5 4PW
    United Kingdom

    Site Not Available

  • Site-001

    Farmington, Connecticut 06030
    United States

    Active - Recruiting

  • Site-001

    Farmington 4834272, Connecticut 4831725 06030
    United States

    Site Not Available

  • Site-003

    Miami Lakes, Florida 33016
    United States

    Active - Recruiting

  • Site-011

    Miami Lakes, Florida 33172
    United States

    Active - Recruiting

  • Site-013

    Orlando, Florida 32806
    United States

    Active - Recruiting

  • Site-005

    Pembroke Pines, Florida 33029
    United States

    Active - Recruiting

  • Site-003

    Miami Lakes 4164186, Florida 4155751 33016
    United States

    Active - Recruiting

  • Site-011

    Miami Lakes 4164186, Florida 4155751 33172
    United States

    Site Not Available

  • Site-005

    Pembroke Pines 4168139, Florida 4155751 33029
    United States

    Site Not Available

  • Site-008

    Lawrenceville, Georgia 30046
    United States

    Active - Recruiting

  • Site-008

    Lawrenceville 4205196, Georgia 4197000 30046
    United States

    Site Not Available

  • Site-009

    Hinsdale, Illinois 60521
    United States

    Active - Recruiting

  • Site-009

    Hinsdale 4896012, Illinois 4896861 60521
    United States

    Site Not Available

  • Site-012

    Indianapolis, Indiana 46268
    United States

    Active - Recruiting

  • Site-012

    Indianapolis 4259418, Indiana 4921868 46268
    United States

    Site Not Available

  • Site-006

    Chesterfield, Missouri 63017
    United States

    Active - Recruiting

  • Site-006

    Chesterfield 4381072, Missouri 4398678 63017
    United States

    Site Not Available

  • Site-002

    Dakota Dunes, South Dakota 57049
    United States

    Active - Recruiting

  • Site-002

    Dakota Dunes 5227180, South Dakota 5769223 57049
    United States

    Site Not Available

  • Site-004

    Houston, Texas 77099
    United States

    Active - Recruiting

  • Site-004

    Houston 4699066, Texas 4736286 77099
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.